The US Food and Drug Administration has extended the authorization of the Pfizer-BioNTech vaccine to 12- to 15-year-olds, and the Centers for Disease Control and Prevention is expected to recommend the expanded eligibility as early as Wednesday.
The US Food and Drug Administration has extended the authorization of the Pfizer-BioNTech vaccine to 12- to 15-year-olds, and the Centers for Disease Control and Prevention is expected to recommend the expanded eligibility as early as Wednesday.
